Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.

Abstract :

Small cell lung cancer (SCLC) is the most aggressive carcinoma in thoracic oncology, unfortunately, despite chemotherapy, relapse is constant. The effect of etoposide, a major drug used against SCLC, can potentially be enhanced after its encapsulation in nanocarriers. The aim of this study was to use the technology of lipid nanocapsules (LNCs) to obtain nanocarriers with drug loadings compatible with clinical use and with an industrial process. Solubility studies with different co-solvent were first performed, then several process were developed to obtain LNCs. LNCs were then characterized (size, zeta potential, and drug loading). The best formulation called Ω-LNCs had a size of 54.1±2.0 nm and a zeta potential of -5.8±3.5 mV and a etoposide drug loading of 5.7±0.3mg/g. The characteristics of this formulation were maintained after freeze drying and after a 15× scale-up. Release studies in a media mimicking plasma composition showed that 40% of the drug was released from the LNCs after 48 h. Moreover the activity of etoposide after encapsulation was enhanced on H209 cells, IC50 was 100 μM and 2.5 μM for etoposide and etoposide LNCs respectively. Unfortunately the formulation failed to be more cytotoxic than etoposide alone on H69AR cells that are resistant to etoposide. This study showed that is was possible to obtain a new etoposide nanocarrier without the use of organic solvent, that the process is suitable for scale-up and freeze drying and finally that etoposide activity is maintained which is very promising for future treatment of SCLC.

Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Okina Université d'Angers <>
Soumis le : mercredi 17 mars 2021 - 11:12:29
Dernière modification le : jeudi 18 mars 2021 - 03:20:12
Archivage à long terme le : : lundi 21 juin 2021 - 08:48:53


Accord explicite pour ce dépôt




Benjamin Saliou, Olivier Thomas, Nolwenn Lautram, Anne Clavreul, José Hureaux, et al.. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.. European Journal of Pharmaceutical Sciences Official Journal of the European Federation For Pharmaceutical Sciences, 2013, 50, pp.172-80. ⟨10.1016/j.ejps.2013.06.013⟩. ⟨hal-03171789⟩



Consultations de la notice


Téléchargements de fichiers